BiopSense
Automated liquid-biopsy sample processing devices and services for cancer diagnostics and monitoring
Highlights
- New on EvolcAdded 2026-10-30
About BiopSense
BiopSense develops devices and services for cancer diagnosis and monitoring using liquid biopsy. Its cartridge automates cell-free nucleic acid extraction from blood and is designed to support sample transfer and analysis without centrifugation or manual preparation steps.
The company serves oncology and diagnostics workflows, including healthcare settings that collect blood samples for biomarker analysis. It was founded in Finland in 2019 and is based in Jyväskylä; BiopSense originated from a research project at the University of Jyväskylä.
Product: Automated cartridges and services for extracting and transferring cell-free nucleic acids and other blood-based biomarkers for liquid-biopsy testing.
Jobs at BiopSense
More health & medtech companies
Bioretec
Absorbable orthopedic implants for bone fracture fixation, sold for use in surgery worldwideNew on EvolcBodily
Movement coaching and online training for individuals, helping them improve body movement chains in Joensuu and remotelyYoung companyNew on EvolcBone Index Finland
Radiation-free osteoporosis screening device for clinics, screening providers and orthopedic practicesNew on EvolcBotnia Kodit
Residential child welfare and foster care services for children and young people in FinlandYoung companyNew on EvolcBrightlife
Billing and patient records software for private psychotherapists in Finland, with Kanta integrationYoung companyNew on EvolcBuddy Healthcare
Care coordination platform connecting hospitals with patients for pre- and post-operative pathways and remote monitoringNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- PHP
- WordPress
- jQuery
- nginx